Dr. Trigo, José Manuel
Director of Oncology, Research and Innovation
Between 5% and 10% of breast cancers are inherited and are part of what are known as hereditary cancer syndromes. Specific mutations in certain genes, such as BRCA1 and BRCA2 as well as other less prevalent genes, increase the risk of breast cancer and other associated cancers such as cancer of the ovary, pancreas, or prostate in men, in those who are carriers.
The identification of the BRCA1 and BRCA2 mutations has enabled great strides to be made in the prevention and early detection of breast cancer.
Dr. Trigo, José Manuel
Director of Oncology, Research and Innovation
Dr. Jiménez Rodríguez, Begoña
Specialist in Medical Oncology
Clinical Dedication in Breast and Gynecological Cancer
Dr. Sedano Ferreras, Paula
Radiotherapy Oncology Specialist
Dr. García Baltar, José Antonio
Especialista en Radiofísica Hospitalaria
Dr. Rebollo García, Natividad
HC Marbella Radiology Specialist
Dr. Escobar, Ángela
Ginecología y Obstetricia, especialista en la Unidad de Mama
Dr. Bellinvia, Anna Alessandra
HC Marbella Radiology Specialist
Dr. Gerchunoff, José Ignacio
Finecología y obstetricia, especialista en la Unidad de Mama
Dr. Arrazola, Tomás
Especialista en Farmacia Hospitalaria
Especializado en terapia contra el cáncer, certificado por la Sociedad Americana de Farmacéuticos de Hospital
Dr. López Ibor, Javier
Mental Health
Clinical and Forensic Neuropsychology
Dr. Di Mauro, Pietro
Specialist in the Plastic and Reconstructive Surgery Unit
Online appointment and download of test results through My HC.
Tel.: +34 952 908 628
952908898 Oncology
951829978 Diagnosis by imaging
951829947 Gynecology
952908897 Fertility
951829947 Physiotherapy